Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Geographical variation and incidence of inflammatory bowel disease among US women.
Khalili H, Huang ES, Ananthakrishnan AN, Higuchi L, Richter JM, Fuchs CS, Chan AT.
Gut. 2012 Jan 11. [Epub ahead of print]
Related citations
Mesenteric fat in Crohn's disease: the hot spot of inflammation?
Siegmund B.
Gut. 2012 Jan;61(1):3-5. Epub 2011 Nov 7. No abstract available.
Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.
Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, Saudemont A, Tachon M, Béclin E, Odou MF, Neut C, Colombel JF, Desreumaux P.
Gut. 2012 Jan;61(1):78-85. Epub 2011 Sep 21.
Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
Zulian A, Cancello R, Micheletto G, Gentilini D, Gilardini L, Danelli P, Invitti C.
Gut. 2012 Jan;61(1):86-94. Epub 2011 Sep 19.
Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases.
Op De Beéck K, Vermeire S, Rutgeerts P, Bossuyt X.
Gut. 2012 Jan;61(1):162-4; author reply 164-5. Epub 2010 Dec 29. No abstract available.
Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options.
Siegel CA.
Gut. 2012 Mar;61(3):459-65. Epub 2011 Dec 20. Review.
Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study.
Jess T, Frisch M, Jørgensen KT, Pedersen BV, Nielsen NM.
Gut. 2011 Dec 19. [Epub ahead of print]
Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
Beaugerie L.
Gut. 2012 Apr;61(4):476-83. Epub 2011 Dec 9. Review. No abstract available.
Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change.
Ordás I, Feagan BG, Sandborn WJ.
Gut. 2011 Dec;60(12):1754-63. Epub 2011 Oct 13. Review.
The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis.
Sheng YH, Lourie R, Lindén SK, Jeffery PL, Roche D, Tran TV, Png CW, Waterhouse N, Sutton P, Florin TH, McGuckin MA.
Gut. 2011 Dec;60(12):1661-70. Epub 2011 Jun 2.
New IBD genetics: common pathways with other diseases.
Lees CW, Barrett JC, Parkes M, Satsangi J.
Gut. 2011 Dec;60(12):1739-53. Epub 2011 Feb 7. Review.
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease.
Kiesslich R, Duckworth CA, Moussata D, Gloeckner A, Lim LG, Goetz M, Pritchard DM, Galle PR, Neurath MF, Watson AJ.
Gut. 2011 Nov 24. [Epub ahead of print]
New therapies for inflammatory bowel disease: from the bench to the bedside.
Danese S.
Gut. 2012 Jun;61(6):918-32. Epub 2011 Nov 23.
TNFα inhibitors restrict T cell activation and cycling via Notch-1 signalling in inflammatory bowel disease.
Werner L, Berndt U, Paclik D, Danese S, Schirbel A, Sturm A.
Gut. 2012 Jul;61(7):1016-27. Epub 2011 Nov 7.
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection.
Haas A, Zimmermann K, Graw F, Slack E, Rusert P, Ledergerber B, Bossart W, Weber R, Thurnheer MC, Battegay M, Hirschel B, Vernazza P, Patuto N, Macpherson AJ, Günthard HF, Oxenius A; Swiss HIV Cohort Study.
Gut. 2011 Nov;60(11):1506-19. Epub 2011 Apr 21.
SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.
Uza N, Nakase H, Yamamoto S, Yoshino T, Takeda Y, Ueno S, Inoue S, Mikami S, Matsuura M, Shimaoka T, Kume N, Minami M, Yonehara S, Ikeuchi H, Chiba T.
Gut. 2011 Nov;60(11):1494-505. Epub 2011 Apr 6.
Crohn's disease: NOD2, autophagy and ER stress converge.
Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A.
Gut. 2011 Nov;60(11):1580-8. Epub 2011 Jan 19. Review.
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lémann M, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Bernhardt CA, Mary JY, Sandborn WJ.
Gut. 2012 Apr;61(4):535-42. Epub 2011 Oct 13.
Colitis-associated cancer: the dark side of inflammatory bowel disease.
Danese S, Malesci A, Vetrano S.
Gut. 2011 Dec;60(12):1609-10. Epub 2011 Oct 13. No abstract available.
Role of biological therapy for inflammatory bowel disease in developing countries.
Rogler G, Bernstein CN, Sood A, Goh KL, Yamamoto-Furusho JK, Abbas Z, Fried M.
Gut. 2012 May;61(5):706-12. Epub 2011 Oct 13.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on